Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised SBB in connection with a directed share issue
Mandate

Vinge has advised SBB in connection with a directed share issue

November 24, 2021 Capital Markets and Public M&A

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with a directed share issue, whereby SBB receives proceeds of approximately MSEK 500.


The subscription price amounts to SEK 70 per Class B common share, which corresponds to a premium of approximately 3.95 percent compared with the closing price for the Class B common share prior to the issue. The new share issue was directed to Gösta Welandson with related parties as well as Wallenstam AB.

Vinge’s team consisted of Jesper Schönbeck, Rikard Lindahl, Joel Magnusson and Anna Svensson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025